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1. Introduction  
Methods of early laboratory diagnostics which allow the prevention of diseases and their 
effective treatment, as well as establishing their causes, make a considerable contribution to 
the prevention and treatment of human diseases. A precise diagnosis is directly connected 
with the speed and sensitivity of the applied method of clinical diagnostics. Diagnostic tests 
are also important in pharmacology and pharmacokinetics for estimating the effectiveness 
of medications used in medical treatment and for controlling their digestion. First of all it 
concerns the diagnostics of such widespread diseases of civilisation as cardiovascular and 
coronary heart diseases, diabetes, oncological and infectious diseases. Besides diagnosing 
diseases, laboratory methods must determine genetic predisposition to serious pathologies, 
as well as determine – with high reliability – the quantitative indicator of pathologies when 
they are still in a clinical asymptomatic state.  
The speed of measurements with the use of biosensors has been the reason for close 
attention on the part of experts in clinical laboratory diagnostics. The past decade has seen 
active development of piezoelectric gravimetric immunosensors that provide for the 
intensification of work in performing a considerable number of tests and the reduction of 
the time necessary for medical treatment.  
A piezoelectric immunosensor is an analytical device, the sensitive element of which is a 
piezoelectric resonator with electrodes coated by receptor molecules. An obvious advantage 
of a piezoelectric immunosensor is the possibility to carry out the direct registration of 
biochemical interaction without the introduction of additional labels (fluorescent, enzyme, 
radioactive, luminescent, etc.), which makes it different from other similar devices. Sensors 
are characterised by their fast response, ease of operation, portability, and possibility to be 
included in automatic systems of information collecting and processing. A unique feature of 
piezoelectric immunosensors is the combination of high sensitivity, which is provided by 
the use of a high-frequency piezoelectric transducer as a physical transducer, and selectivity 
which is determined by the nature of employed receptor molecules. An electrode's coating is 
formed on the basis of natural bio-recognizing substances characterized by high selectivity 
of interaction. In order to increase the selectivity and to widen the range of tested 
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substances, which is especially important in the field of medicine and pharmacology, 
piezoelectric immunosensors’ electrode coatings are formed from natural bio-recognizing 
compounds which are characterized by high selectivity of interaction.  
Currently antibodies – protective proteins formed in the organisms of higher animals in 
response to the introduction of foreign agents – antigens (nucleic acids DNA and RNA, 
carbohydrates, etc.) – are most frequently used as key reagents. Both in the living organism 
and outside it antibodies are capable of forming immune complexes with a complementary 
antigen (or hapten), despite the presence of a great number of other components in the sample. 
A number of reviews (Vaughan et al. 2007, Ermolaeva et al. 2008, Skladal 2003) are devoted 
to considering the theoretical aspects of piezoelectric immunosensors functioning and the 
peculiarities of their practical application in determining various analytes. 
Gravimetric piezoelectric sensors, named a piezoquartz microbalance (quartz crystal 
microbalance, QCM), are high-frequency transducers (with the basic frequency of 5-15 
MHz) made from an AT-cut quartz crystal. The analytical signal of such a sensor is most 
commonly the reduction of the oscillation frequency of the resonator with the increase of the 
receptor layer’s mass as a result of its interaction with determined substances. Frequency 
variation of the oscillating crystal depending on change of the mass fixed on a quartz 
surface is described by the Sauerbrey equation (Sauerbrey 1959) for rigid, uniform and thin 
adsorptive layers: 
Δm=C · Δ f, 
where m – mass, C – proportionality coefficient, f – crystal oscillation frequency. 
There can be a deviation from the Sauerbrey equation and errors in mass measurement for 
soft or viscous-elastic films which are not fully contacting the oscillatory crystal, therefore it 
is necessary to standardize (calibrate) a QCM sensor before testing various liquid samples. 
The analysis of liquids with the use of piezoelectric sensors can be carried out both in static 
and flowing modes. In the first case (the procedure being known as «dip and dry») the 
increase of the receptor layer’s mass is measured before and after the contact of the sensor 
with the analyzed liquid sample and the following air drying up to the constant mass. The 
use of the sensor as the detector of the flow-injection analysis makes it possible to raise the 
speed of determination, and also provides the opportunity to observe immunochemical 
reactions in real time. 
The creation of gravimetric biosensors of various designs (test-means, detectors for flow-
injection analysis) on the basis of highly specific interactions (antibody-antigen, receptor-
ligand, etc.) can expand their range of applications in medicine with the aim of identifying 
not only toxic micro-organisms, but specific substances that act as a sort of precursors of 
dangerous diseases. 
2. The features of registration of biochemical interactions with the help of 
piezoelectric immunosensors  
The most developed types of immunoassay with the use of piezoelectric transducers are the 
following: direct, indirect (competitive) and displacing (Ermolaeva et al. 2006, Su et al. 2003). 
www.intechopen.com
Capabilities of Piezoelectric Immunosensors  
for Detecting Infections and for Early Clinical Diagnostics 
 
83 
The sandwich assay and some other ways of amplifying the analytical signal are 
recommended for increasing the sensitivity of determinations. 
Direct detection is used to determine somatic cells, micro-organisms and macromolecules 
(proteins, antibodies, nucleic acids, glycoproteins, glycolipids, etc.). It is implemented in one 
step when analyte contacts the sensor's receptor layer. The decrease of resonant frequency 
due to the formation of the complex on the surface of the electrode is directly proportional 
to the concentration of the determined component (Fig. 1).  
 
Fig. 1. The scheme of the direct assay of the antibody using piezoelectric immunosensors: 1 - 
antigen (hapten); 2 - specific antibody; 3 - non-specific components of the mixture 
The sensor’s electrodes are modified by antigens or antibodies (mono- or polyclonal). 
Usually the sensor is previously treated with a solution of a non-ionic surfactant or an 
inactive protein (BSA, gelatine, etc.) in order to increase the selectivity of determination. 
Such proteins do not cross-interact with the components of the sample but connect with 
non-specific sites of the sensor’s receptor layer. For example, the sensor’s receptor layer 
based on DNA interacts weakly with BSA molecules, causing only a slight frequency signal 
(not more than 5 Hz), while the serum of patients with symptoms of an autoimmune 
disease, containing antibodies to DNA, gives an analytical signal on the level of hundreds of 
Hz (Kalmykova et al. 2002). In order to determine small molecules the indirect/competitive 
analysis, the sandwiched assay and other types of analysis are used. 
The competitive analysis of haptens with the use of piezoelectric sensors (U. S. Patent 
4,242,096 1980) was first performed in 1980. While in a routine immunochemical analysis, 
free and labelled analytes presented in the sample compete for binding with antibodies, in 
the case of piezoelectric immunosensors the competition takes place between free analyte 
(hapten) and hapten-protein conjugate immobilized onto the bioreceptor layer. The value of 
the obtained analytical signal of the sensor is inversely proportional to the concentration of 
hapten in the sample. The essence of this method is illustrated in Fig. 2.  
Such a method has been successfully used for determining different low-molecular-mass 
haptens: vitamins, drugs, hormones, metabolites, etc. The detection limit of the competitive 
analysis is lower compared with that of the direct one (Prusak-Sochaczewski et al. 1990), but 
the range of determined concentrations is narrower by a factor of 10 to 100. In order to apply 
the competitive analysis, the receptor layer can be formed on the basis of both hapten-protein 
conjugates and antibodies. In the latter case a fixed quantity of hapten-protein conjugate is 
added to each sample. This type is known as the alternative competitive assay (Fig. 3).  
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Fig. 2. The scheme of the competitive (indirect) assay using piezoelectric immunosensors: 1 - 
hapten-protein conjugate; 2 - hapten; 3 - antibody 
 
Fig. 3. The scheme of the alternative competitive assay using piezoelectric immunosensors: 1 
- antibody; 2 - hapten; 3 - hapten-protein conjugate 
Conjugated and free haptens are equally probably bound with the active sites of 
immobilized antibodies. Therefore, the lower the concentration of free analyte in a sample, 
the greater the conjugated hapten attached to the sensor’s receptor layer. Thus, the sorption 
of the conjugated analyte provides for a significant amplification of the registered signal. 
Despite a lower sensitivity, the alternative method is characterized by a wider range of 
determined concentrations in comparison with the competitive assay.  
The displacement assay has been successfully used to characterize the stability of the affine 
complexes (antibody - antigen, DNA - protein, DNA - RNA, etc.), to study the kinetics of 
dissociation, and to solve a number of problems dealing with analyte concentration 
determination. While the competitive assay is preferable for determining low concentrations 
of small molecules, the displacement assay is more convenient for detecting 
macromolecules. The principle of determination consists of measuring the heterogeneous 
complex’s mass reduction as a result of dissociation under the influence of an excess of one 
of the components. The analysis is carried out in two stages (Fig. 4).  
An example of this type of immunoassay may be the determination of Listeria monocytogen 
(Minunni et al. 1996) micro-organisms in milk (at 2.5·105 – 2.5·107cells·ml-1). The decrease of 
the frequency of the sensor is caused by binding specific antibodies in a sample of milk with 
a protein antigen extracted from L. monocytogenes cells and pre-immobilized on the electrode 
surface. In the second stage the L. monocytogenes cells additionally introduced into the 
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sample of milk cause the displacement of antibodies in immune complex. The number of 
displaced antibodies is directly proportional to the concentration of L. monocytogenes cells in 
the sample. A similar method was proposed to determine the P. aeruginosa bacteria in 
samples of milk and drinking water (Bovenizer et al. 1998). 
 
Fig. 4. The scheme of the displacement assay using piezoelectric immunosensors: 1 - antigen, 
2 - specific antibody  
The sandwich assay is carried out in two stages with the use of two types of antibodies 
(U.S. Patent, 4,314,821 1982). In the first stage the antibodies immobilized on the electrode 
surface are bound with the analyte, in the second stage the "sandwich" structure is formed 
with other types of antibodies being additionally introduced (Fig. 5). A method for 
determining human serum albumin based on the formation of the complex with two types 
of antibodies can serve as an illustration of the successful application of the sandwich assay 
(Saber et al. 2002). In this example the analytical signal of the sensor is 3 times higher than 
the same value obtained by the direct detection. 
 
Fig. 5. The scheme of the sandwich assay using piezoelectric immunosensors: 1 - specific 
antibody; 2 - antigen 
In order to reduce the detection limit other methods are used along with the sandwich assay 
that will increase the value of the analytical signal, e.g. modification of reagents with 
nanoparticles of different nature (secondary antibodies, metal colloidal particles, polymers 
nanoparticles and liposomes), which significantly increase the size and mass of the detected 
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complexes formed at the solid phase (Aizawa et al. 2001, Kim et al. 2007, Chu et al. 2006). In 
(Su et al. 2000), such methods are marked as a separate kind of analysis, namely the analysis 
with signal amplification (mass amplified assay) (Fig. 6.).  
The application of secondary (anti-species) antibodies that interact with the antibodies of the 
immune complex increases the analytical signal and decreases the detection limit only 1.5 - 2 
times, since the mass of secondary antibodies does not exceed 150 kDa. For example, the 
detection limit of steroid hormone was thus reduced from 12 to 7ng·ml-1 (Kubitschko et al. 
1997). The mass-amplified assay is operated in two stages. In the first stage the immobilized 
antigen is bound with defined antibodies. In the second stage – after the removal of 
antibodies unbound during the first stage – secondary antibodies are introduced which are 
bound only to specific antibodies. An example of using this method is the determination of 
allergen-specific immunoglobulin (IgE) in serum of patients with the symptoms of allergic 
dermatitis (Su et al. 2000). An allergenic protein is immobilized on the surface of the sensor’s 
electrode. In the first stage antibodies of different classes were bound on the surface of the 
receptor’s layer during the contact of the sensor with the patient's blood serum sample. In 
the second stage the differentiation of antibodies after adsorption of secondary antibodies to 
human IgE in the process of contact with the sensor was carried out. The differentiation of 
allergen-specific antibodies (IgE) from other classes of immunoglobulins (IgG and IgM) 
contained in blood serum is possible after application of these secondary antibodies.  
 
Fig. 6. The scheme of the competitive assay with signal amplification by secondary 
antibodies using piezoelectric immunosensors: 1 – hapten; 2- anti-hapten antibodies; 3 - non-
specific antibody; 4 - secondary antibody 
A more significant reduction in the detection limit of analytes (Aizawa et al. 2001, Kim et al. 
1996, Liu et al. 2007, Grieshaber et al. 2008, Reyes et al. 2009, Han et al. 2011, Wei et al. 2010, 
Kim et al. 2010) was observed in the application of colloidal particles of gold, lead, cadmium 
or zinc sulphides, chromium, titanium and iron oxides, as well as composite particles based 
on liposomes or latex modified by antibodies.  
The colloidal particles modified by antibodies can be applied in all types of analysis 
reviewed above with the purpose of increasing the signal of the sensor. For example this 
approach was applied to the determination of the E. coli bacteria in the range of 106-108 
cells·ml-1(Liu et al. 2007). 
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Antibodies immobilized on the electrode of the sensor interacted with E. coli bacterial cells 
in the analyzed sample. After that the particles of latex with bound E. coli-antibodies were 
introduced into the reaction mixture to form a sandwich complex with cells that had already 
been bound with antibodies on the surface of the electrode of the sensor. 
Thus, the application of nanoparticles of various masses makes it possible to increase the 
signal and to change the detection limit of analytes in the sample. However, in choosing the 
nanoparticles it is necessary to exclude their non-specific interactions with the components 
of the sample which lead to a distortion of the results of the analysis. 
3. Application of piezoelectric immunosensors for medical diagnostics 
Various metabolic biomarkers (substances that appear in biological fluids and tissues of the 
human body during the development of many somatic and infectious pathological 
processes) can be used in medical and biological research. The determination of these 
substances allows for diagnosis of diseases at early stages. An urgent problem in the clinical 
analysis is the need to detect single cells and micro-organisms. In this connection, along 
with speed, high sensitivity and selectivity, one of the main requirements in performing a 
large number of routine analyses is the simplicity in preparation of samples for the analysis. 
Piezoelectric immunosensors are used primarily to identify markers associated with 
oncological, cardiovascular, autoimmune, allergic and infectious diseases. The nature of 
molecular markers is quite diverse – they are specific proteins (antibodies, enzymes) and 
non-specific protein molecules, glycoproteins and glicoconjugates, modified alkaloids, 
hormones, steroids, drugs and other high- or low-molecular metabolites (Wu et al. 2007, 
Simon 2010, Martínez-Rivas et al. 2010, Bohunicky et al. 2011, Keusgen 2002, Malhotra et al. 
2003, Georganopoulou et al. 2000, Mascini et al. 2008). In addition, sensors can be used to 
identify microorganisms – bacteria, viruses, and phages. Let us review in more detail the 
results of research on the sensors for determining the most important groups of biomarkers. 
3.1 Tumour markers 
Oncological diseases are still the most common threatening ailments, therefore it is not 
surprising that the search continues for not only new pharmaceutical products but 
diagnostic methods facilitating the detection of pathology at early stages.  
In order to identify certain types of cancer so-called tumour markers are used, conventionally 
divided into specific and non-specific ones. Tumour markers are complex substances, mainly 
glyco- or lipoproteins, that are produced by tumour cells much more intensively than normal 
ones (Wu et al 2007, Guillo et al 2008, Justino et al. 2010). Usually the present marker is 
determined by a blood test giving a positive result in the presence of malignancy. Different 
tumour cells produce a variety of markers with different chemical structure. 
In creating immunosensors much attention is paid to immobilization of receptor 
biomolecules in the formation of the detecting layer whose quality determines the basic 
characteristics of the sensor (Ding et al. 2007, Chang et al. 2010), namely sensitivity, 
selectivity and stability (reproducibility of measurements and stability for repeated 
application of the biolayer). The creation of "bioreactors" with high-density and spatial 
availability of binding sites of receptor biomolecules is a new approach to obtaining detecting 
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electrode coatings of piezoelectric resonators, which allows multiple determinations without 
the regeneration of the sensor’s biolayer. 
The largest number of piezoelectric immunosensors presented in the literature is intended 
for the detection of such specific antigens as the marker of ovarian carcinomas CA 125; 
pancreatic cancer CA 19-9 and prostate specific antigen (PSA); carcinoembryonic antigen 
(CEA) that appears with carcinoma of the cervix or with the developing fetus. In order to 
determine low concentrations of tumour markers, various techniques aimed at increasing 
detection sensitivity are used. One of the methods of immobilizing bioreceptor molecules is 
to use nanoparticles of various nature – magnetic (Chen et al 2007, Wei et al. 2010) or gold 
(Tang et al. 2006, Tang et al. 2008, Uludağ and Tothill 2010), as well as calixarene (Lee et al. 
2003). 
Magnetic nanoparticles based on CoFe2O4/SiO2 are used to obtain a detection layer 
containing specific antibodies to SEA (Chen et al 2007). It is possible to determine 
carcinoembryonic antigen using this sensor in the range of 2.5 – 55 ng·ml-1 with the 
detection limit of 0.5 ng·ml-1. Since the normal concentration of tumour marker levels does 
not exceed 2.5 ng·ml-1 for non-smokers and 5 ng·ml-1 for smokers, the proposed 
immunosensor system can detect even a slight increase in the level of antigen in blood, 
demonstrating stability of work and satisfactory reproducibility of measurements.  
In addition to magnetic particles, gold nanoparticles (Tang et al. 2006) and chains on the 
basis of nanoparticles (Tang et al. 2008) are used to amplify the sensor’s signal and increase 
the number of active sites on the selective surface. 
Gold nanoparticles of optimal length with immobilized antibodies are proposed as a 
biolayer of the sensor (Tang et al. 2008) for the determination of antigen CA 125. These 
structures are a result of a multi-stage process with the use of 2-aminoethanethiol (AET) 
bifunctional molecules with amino- and thiol terminal groups and the following reduction 
of gold by sodium borohydride (Fig. 7). 
  
Fig. 7. The formation of the receptor layer on the surface of the gold electrode: Stage I - 
nano-chains generation of molecules HAuCl4 and AET; Stage II - immobilization of 
antibodies (Tang et al. 2008). 
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In the process of the preparation of the biolayer the AET solution (pH 4.5) is put on the clean 
gold surface of the electrode and exposed for 2 hours at 4°C. Adjustment of AET molecules 
is achieved by coordinating bindings between sulphur and gold atoms. Chains from gold 
nanoparticles are formed as a result of multiple successive putting the HAuCl4 solution and 
AET due to the binding of ions [AuCl4]- with NH2- and SH-groups of AET and the formation 
of self-organizing layers {AuCl4-/AET}. This technique of obtaining electrode coating 
provides the sequence of layers, and after the reduction of anions [AuCl4]- by the sodium 
borohydride (NaBH4) water solution chains from gold nanoparticles are formed. The 
process is accompanied by a change in the colour of the surface from yellow to deep red. 
The addition of the antibody solution results in fixation of the molecules of specific 
immunoglobulins with the space-available active sites on the gold particles.  
Therefore the presence of gold nanoparticles and nanochains (nanosequences) on the surface 
of the sensor's electrode increases the number and density of immobilized antibodies, as 
well as facilitates the formation of a three-dimensional structure in the biolayer, as 
confirmed by the methods of atomic force and electron microscopy at stepwise formation on 
the surface of the receptor layer. The detection layers based on gold nanoparticles and 
nanochains (nanosequences) exhibit high selectivity which is confirmed by the analysis of 
solutions containing interfering antigens such as CEA, CA 199, ǂ-fetoprotein and hepatitis B 
surface antigen. It is shown that even high concentrations of impure antigens do not 
significantly affect the determination of CA 125, whose concentration in serum does not 
normally exceed 25 U·ml-1. The biolayer obtained with the use of gold nanoparticles has 
high capacity, satisfactory stability and provides good reproducibility of the analytical 
signal of the sensor. The linear range of determined concentrations of CEA and CA 17 125 
(Tang et al. 2008) is 3.0 - 50 ng·ml-1 and 1.5 - 180 U·ml-1 respectively, with the detection limit 
being 1.5 ng·ml-1 and 0.5 U·ml-1. The results of the analysis of human blood serum obtained 
with the use of piezoelectric immunosensors correlate with those of enzyme immunoassay. 
However, an advantage of sensor technologies is higher speed and simplicity of 
measurement, eliminating the stages of the introduction of an enzyme label, of separation 
and washing, which is important when conducting a large number of clinical tests. 
A new approach to the formation of the detection layer with a higher capacity is realized in the 
design of the sensor, proposed for determining carbohydrate antigen CA 19-9, which is a 
marker of pancreatic (Ding et al., 2008, Tanaka et al. 2000), colon (Nakayama et al., 1997), liver 
(Uenishi et al. 2003) cancer. The possibility of using organo-inorganic hybrid nanomaterials 
based on hydroxyapatite [HA, Ca10(PO4)6(OH)2] and lysine is shown. Hydroxyapatite is the 
main inorganic component of bones, characterized by exceptional biocompatibility and 
therefore not causing immune rejection or toxic effects on the body (Ding et al., 2008). 
However, the use of pure materials on the basis of hydroxyapatite is hampered by instability, 
fragility and low solubility of the mineral. The addition of an organic component improves 
physical and chemical properties (such as permeability, solubility, etc.). The biosensor’s 
receptor layer is formed on the basis of specific antibodies attached to a hybrid nanocomposite 
consisting of poly-L-lysine/hydroxyapatite/carbon nano-tubes (Fig. 8). 
In order to obtain the coating, the resonator is initially treated with mercaptopropionic acid, 
which leads to the functionalization of the gold electrode surface by carboxyl groups as a 
monolayer. Further addition of 1-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) 
and N-hydroxysuccinimide (NHS) provides the activation of carboxyl groups. After 
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washing and drying the resonator a suspension composed of poly-L-lysine, hydroxyappatite, 
carbon nanotubes is put on the surface of the resonator’s electrode and exposed for 2 h at 
37°C, then antibodies to CA 19-9 are immobilized after the washing. The biosensor with 
nanocomposite detecting coating provides the direct registration of the immune complex 
which is formed in the process of the sorption of the tumour marker (a high molecular 
glycoprotein with the molecular weight of approximately 20.000) as an increase of the mass 
of the biolayer in the range from 12.5 to 270 U·ml-1. The content of CA 19-9 antigen in 
healthy people is less than 37 IU·ml-1, so a piezoelectric immunosensor can detect even 
slight deviations from the norm and diagnose the disease at an early stage. 
 
Fig. 8. The formation of the biolayer based on antibodies to CA 19-9, immobilized with poly-
L-lysine/hydroxyapatite/carbon nano-tubes (Ding et al. 2008).  
The combination of the methods reviewed above (application of new hybrid materials on 
the basis of gold nanoparticles and hydroxyapatites (Ding et al. 2007) and subsequent 
immobilization of antibodies) increases the sensitivity and widens the range of 
concentrations of the marker. The authors have shown that the use of selecting surface of the 
sensor with nanoparticles leads to the increase of the biolayer’s binding activity with 
immobilized antibodies to ǂ-fetoprotein (Ab-AFP). The immunosensor is designed to detect 
ǂ-fetoprotein (a glycoprotein with a molecular weight of 65 - 70 kDa, which is a marker of 
trophoblastic tumors (Chou et al. 2002) in the range of 15.3 - 600.0 ng·ml
-1
). 
Along with new ways of immobilization, traditional approaches to the formation of the bio-
detecting layer of the sensor still remain popular. Methods of immobilizing specific 
monoclonal Ab-AFP (physical sorption, attachment to substrates based on protein A and 
concanavalin A, cystamine with the use of a cross-reactant - glutaraldehyde - GA) are 
studied in detail. The highest stability was shown for the biolayer obtained using the self-
organizing monolayers on the basis of cystamine. The sensor provides the detection of even 
minor deviations of AFP from the norm (20 ng·ml-1 in human serum), as the linear range of 
determined concentrations of glycoprotein corresponds to 0.1-100 ng·ml-1 (Tatsuta et al. 
1986). The results of determining AFP in serum samples correlated with the data of the 
radioimmunoassay. 
In order to increase the stability of the biolayer a method of immobilizing protein molecules 
(antigens or antibodies) is proposed using the bifunctional linkers and calixarenes 
“Prolinkers” (Lee et al. 2003). It is shown that the activation of a solid surface by Prolinkers 
(Fig. 9) allows bioreceptor layers to be obtained with high density and vertical position of 
the molecules and hence a high concentration of spatially available binding sites for 
immobilized antigens or antibodies.  
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The active sites of the receptor molecules are not affected, which usually occurs in 
immunoglobulin covalent fixing. Immobilization is accomplished by including proteins in 
the calixarene cavity with the formation of the host-guest complex, as well as a result of 
hydrophobic interactions. The fixation of the linker on the metal surface is achieved by 
means of sulphur atoms or carbonyl groups comprising Prolinker B or A, respectively. The 
considered method of forming the biolayer provides high sensitivity of determination of 
such tumour markers as hCG (chorioiditic gonadotropin), CEA, ǂ-fetoprotein, ferritin, etc. at 
the fg·ml-1 level 
 
Prolinker В 
 
Prolinker А 
Fig. 9. The scheme for obtaining the biolayer based on Prolinkers (Lee et al. 2003) 
A flow-injection sensor has been designed to determine mezotelin (a glycoprotein with the 
weight of 40 kDa) which like the C 19-9 antigen is associated with pancreatic cancer 
processes (Corso et al. 2006) and is present in blood practically in all pancreatic 
adenocarcinomas. The detecting coating of the sensor is obtained on the basis of mezotelin-
specific antibodies immobilized on the self-organized alkanthiol monolayers.  
The increase in sensitivity and reliability of tumour marker determination is achieved not 
only by the formation of the receptor layer with a high concentration of available binding 
sites but also by improving the methods of determining the equipment, which allow 
monitoring of immunochemical interactions in real time. The improvement of the "signal-
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noise" ratio and the reduction of the contribution of nonspecific interactions occur when 
taking measurements using a system of two sensors: the indicator sensor and the 
comparison sensor, both placed in individual flow cells (Fig. 10).  
 
Fig. 10. The diagram of the device for performing the flow analysis (Corso et al. 2006)  
The use of two syringe pumps (to feed the carrying solution and the sample solution) 
reduces pulsations in the system and allows the stabilization of the sensor signal, while 
determining mezotelin at the nano-level (Corso et al. 2006). 
As seen from the above examples, piezoelectric immunosensors are a highly sensitive tool 
for detecting low concentrations of tumour markers and for identifying the disease at early 
stages. Most commonly, however, sensors are used for detecting recurrences of cancer 
previously diagnosed and treated for. This is due to the nature of antigenic tumour markers 
which can give false positive reactions. 
The reliability of diagnosis increases with the use of biochips and multisensor systems 
consisting of a set of sensors for determining individual tumour markers and metabolites, 
complicating the diagnosis of cancer. Thus, a multi-sensor system is described designed for 
highly specific determination of several tumour markers in serum, such as ǂ-fetoprotein, 
CEA and carcinoma antigen, prostate-specific antigen (Zhang et al. 2007). The possibility of 
the simultaneous determination of several tumour markers, a perfect combination of high 
speed and relatively low cost makes the approach attractive compared with traditional 
diagnostic laboratory methods. The detection limits of PSA, AFP, CEA, and CA125 are 1.5 - 
40 ng·ml-1, 20 - 640 ng·ml-1, 1.5 - 30 mg·ml-1, 5 - 150 IU·ml-1, respectively. The comparison of 
the results of the analysis of clinical samples using the multichannel immunosensor and the 
chemiluminescence method showed no significant differences.  
In spite of the fact that specific biomarkers are more informative because they indicate the 
emergence of specific forms of pathological processes, non-specific tumour markers, 
however, such as human serum albumin (HSA) and ferritin have also proved useful in 
assessing the health status of patients.  
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A number of studies are aimed at creating a piezoelectric immunosensor for the 
determination of HSA. The focus is on methods of immobilization, as well as increasing the 
sensitivity of determination from μg·ml-1 to ppm (for example, signal amplification due to 
the use of secondary antibodies in the sandwich-analysis (Sakai et al. 1995) or colloidal 
particles of latex (Xia et al. 1997)). The simplest way to fix biomolecules is the physical 
adsorption in that it, unlike covalent bonding, preserves the activity of immunoglobulins. 
This is due to rather mild conditions of protein immobilization, but the stability of the film 
coating is low, the mass of the bio-layer is already lower after 2 - 4 measuring cycles. 
Immunosensors (Muratsugu et al. 1993) make it possible to determine HSA with high 
sensitivity and selectivity in the range of 0.1 - 100 µg·ml-1 even in the presence of a 
nonspecific impurity protein – bovine serum albumin (BSA). Further development of 
immobilization methods was aimed at increasing the strength of the bio-layer due to a 
substrate on the basis of calixarenes and synthetic polymers (Sakti et al. 2001), which ensures 
the sensor’s long-term operation in analyzing not only sample solutions but real samples of 
biological fluids (e.g., urine). 
At present, the problems of increasing the sensitivity of determining the HSA and the 
stability of the sensor are fully understood. Considerable attention is paid to both methods 
of obtaining the biolayer and ways of amplifying the sensor’s analytical signal. This can be 
achieved by increasing the mass of the heterogeneous immune complex. Secondary 
antibodies whose mass exceeds that of HSA are used in the sandwich assay to amplify the 
signal, which leads to lowering the HAS detection limit to 20 ppm. With the same purpose 
the nano-particles of carboxyethyl cellulose polymer (Xia et al. 1997) are used, thus 
increasing the sensor signal due to latex agglutination. 
Along with the HSA determination considerable attention is paid to the creation of sensors for 
the determination of another non-specific marker – ferritin, a backup protein the level of which 
increases during the inflammatory processes in the body. Methods of immobilizing poly- and 
monoclonal antibodies on the electrode surface have been thoroughly researched. They 
include: physical adsorption, covalent attachment to substrates on the basis of concanavalin A 
and protein A, and self-organizing monolayers on the basis of cystamine, cystamine/GA 
(Chou et al. 2002). It has been shown that the biolayer based on cystamine has the highest 
stability. The sensors remain active for 15 days and can be used up to 10 times in ferritin linear 
concentration range of 0.1 - 100 ng·ml-1. It should be noted that in order to determine tumour 
markers, monoclonal antibodies are more frequently used. This increases the reliability of 
determinations and ousts polyclonal antibodies from the laboratory practice. 
In diagnosing leukemia whole cells (leukocytes) circulating in blood (Wang et al. 2006, Zeng 
et al. 2006) are determined. The receptor coating is formed on the basis of Fab'-SH fragments 
of specific monoclonal antibodies, thus avoiding overloading the sensor. Performing the 
analysis in the automatic mode involves the measurement and regeneration of the biolayer 
in one measurement cycle. The application of 8M of urea as a regeneration solution permits 
keeping the coating stable for up to 17 measurement cycles. Firm fixation of the fragments of 
immunoglobulins is achieved through the formation of covalent bonds between the 
biomolecules and thin-film substrates obtained by plasma polarization of n-butyl amine, on 
the basis of protein A or gold nanoparticles. The sensor is able to quickly and reliably detect 
normal cells, leukemic blasts and to determine the concentration of leukocytes in the range 
of 104 - 106 cells·ml-1. 
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Thus nowadays piezoelectric immunosensors have successfully proved to be promising 
tools for express determination of blood cells and tumour markers of different chemical 
structure and biological specificity.  
3.2 Cardiac markers 
Cardiovascular diseases leading to the growth of cardiac infarctions and strokes remain one 
of the main causes of death and disablement throughout the world. Myocardial necrosis is 
accompanied by the appearance of blood-specific biomarkers – proteins released with the 
destruction of myocytes: myoglobin, cardiac troponin and specific enzymes – creatine 
kinase, glycogen phosphorylase BB (GPBB), lactate dehydrogenase, etc. (Casey 2004). 
Despite a wider application of enzymatic methods of analysis in laboratory diagnostics of 
cardio-pathology, several works of the recent years have described piezoelectric chemical, 
bio- and immunosensors for determining biomarkers of non-enzymatic nature – myoglobin 
(Godber et al. 2005), C-reactive protein (СRP) (Kurosawa et al. 2003, Kim et al. 2009), 
troponin (Wong-ek et al. 2010, Mohammed and Desmulliez 2011), heparin (Cheng et al. 
2002), thrombin, etc.  
Bi-sensor systems are being developed in order to reduce the impact of non-specific effects. 
To change the viscous-elastic properties of the receptor films which influence the 
comprehensiveness of contact of the vibrating crystal with the surface, which in turn causes 
errors in calculating the adsorbed mass. Bi-sensor systems on the basis of high-frequency 
resonators (16.5 MHz) have been developed for determining mioglobin, a cytoplasmatic 
protein with the weight of 17 кDа, a part of muscular cells (Godber et al. 2007), the presence 
of which in blood serves as a good diagnostic marker of cardiac diseases (Casey 2004). The 
receptor layer of the indicator sensor includes anti-mouse-Fc-specific antibodies in the rabbit 
which are immobilized by means of EDC and NHS. Mouse immunoglobulins G are fixed on 
the surface of the control sensor to control a non-specific interaction of mioglobin with the 
surface of the protein. The analytical signal caused by the specific interaction is measured 
relative to the comparison sensor thus providing the opportunity to differentiate between 
the normal level of mioglobin in blood (100 ng·ml-1) and excess at cardio ischemia because 
mioglobin concentration directly after infarction reaches 1000 ng·ml-1 and more and 
decreases to 500 ng·ml-1 after a time. 
The combination of a bi-sensor system and the sandwich assay is directed at increasing the 
sensitivity in determining C-reactive protein (McBride and Cooper 2008), which is a 
multifunctional biomarker of an acute phase playing an important role at inflammations, in 
protection against alien agents, at necroses and autoimmune processes. For a number of 
years the exceeding concentration of СRP by over 5 mg·l-1 marked the absence of any 
systemic inflammatory process in the organism. Now, new data on the diagnostic 
possibilities of СRP, including participation in the development of various pathologies have 
been obtained, particularly vascular diseases. The determination of "background" or "base" 
(hsCRP) concentrations in biological liquids can be used to forecast the degree of risk from 
acute myocardial infarction, a brain stroke, and sudden death in people not suffering from 
cardiovascular diseases. Expansion of the diagnostic status of СRP has demanded the 
development of methods of high-sensitive determination of a biomarker. It is recommended 
to use the calibration graph obtained with the application of human CRP standard solutions 
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(0.3 - 116 ng·ml-1) on the basis of diluted horse blood to decrease irregularities. Sheep anti-
CRP are immobilized on the surface of the indicator sensor, and purified sheep 
immunoglobulins G are immobilized on the control sensor. Such an approach enhances the 
reliability of revealing patients predisposed to cardiovascular diseases. The use of secondary 
antibodies in the second stage of the analysis promotes the increase in specificity and 
sensitivity of determination in comparison with the results of the traditionally used ELISA.  
The works of Japanese researchers are devoted to determining CRP and providing the 
quantitative characteristic of affinity of monoclonal antibodies and their Fab′-fragments 
(Kurosawa et al. 2002 and 2004). They studied the influence of the nature of thin plasma-
polymerized coatings of gold electrodes (styrene, allylamine and acrylic acid) on the 
orientation of immobilized antibodies and their fragments. It was shown that the highest 
analytical signals are observed for biolayers on polyallylamine substrates. Processing the 
electrode by a polymer based on phosphorylcholine and methylacrylate derivatives 
increases the affinity of the receptor molecules to the determined substance and decreases 
the reaction activity in relation to non-specific proteins of human serum. The highest values 
of affinity constants were seen for Fab′-fragments in comparison with the whole antibodies. 
The application of fragments of antibodies allows the achievement of the linear range of 
defined concentrations of C-reactive protein of 0.001 - 100 μg·ml-1 (Kurosawa et al. 2004) in 
serum samples. 
The suggested approaches increase both the speed of diagnostics and the sensitivity and 
reliability of determining cardiac markers. 
3.3 Detection of infections  
The possibility of the spread of epidemic-causing pathogenic germs and the threat of 
bioterrorism necessitate the development of new express methods for detecting pathogens 
for early detection of cases and localization of sources of infection. Control over the spread 
of extremely dangerous, acute intestinal, septic, sexual, viral diseases (influenza, hepatitis, 
HIV) involves not only the identification of bacteria or viruses in biological fluids of patients 
but also the determination of markers of infection – specific antibodies and in some cases – 
toxins (proteins, glycoproteins or glycolipids) produced by pathogenic causative agents. 
The application of piezoelectric immunosensors for determining microbial and bacterial 
antigens, toxins and antibodies (which are large analytes) proved to be more promising not 
only compared with the traditional methods of analysis (microbiological, immunochemical 
and molecular-genetic) but also with other biosensors. This is explained by peculiarities of 
gravimetric detection which does not require the introduction of biochemical markers for 
the registration of binding. This greatly simplifies and speeds up the analysis procedure. 
Piezoelectric micro- and nano-weighing makes it possible both to register the mass of a 
microbe or a biopolymer at µg or ng and to calculate the number of individual cells or 
viruses according to their mass and size in the concentration range of 102 - 107 cells·ml-1 or 
106 - 1010 particles·ml-1, respectively (Pathirana et al. 2000, Konig and Gratzel 1992).  
In determining microorganisms the direct analysis is used most commonly, while the 
sandwich and the displacing assays and the analysis with the amplification of the sensor 
signal are used to increase the sensitivity of determination. 
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The characteristics of piezoelectric immunosensors for determining microorganisms and 
protein molecules are given in tables 1-3.  
 
Analyte 
Method of immobilizing 
receptor molecules or assay 
design (detection format) 
Linear range. 
Detection limit 
References 
Escherichia coli 
O157:H7 
Immobilization on gold 
electrode on the basis of N-
hydroxysuccinimide and 16-
mercaptohexadecanic acid 
103 – 108 CFU·ml-1 
- 
Su and Li 2002 
Escherichia coli 
Covalent immobilization of Ab 
cross-linked by GA 
1.7·105 – 
8.7·10CFU·ml-1 
3·104 – 3·107CFU·ml-1
Adanyi et al. 
2006 
Escherichia coli 
O157:H7 
Biotylated Ab immobilized on
monolayers on protein A 
105 – 107 CFU·ml-1 
102 CFU·ml-1 
Liu et al. 2007 
Ab immobilized on 
monolayers on the basis of 16-
mercaptohexadecanic acid 
(MHDA) with NHS 
- 
2.0·102 CFU·ml-1 
Wang et al. 
2008 
Francisella 
 tularensis 
Ab immobilized via protein A 
104 – 109 CFU·ml-1; 
105 CFU·ml-1 
Pohanka et al. 
2007 
Ab immobilized to monolayer 
cystamine/GA 
- 
- 
Pohanka et al. 
2007 
 
Mycobacterium 
 tuberculosis 
Immobilization of Ab on silver 
electrode via protein A 
105- 108 cells·ml-1. 
105 cells·ml-1 
He and Zhang 
2002 
Salmonella sp. 
Direct detection, 
Ab immobilized with cross-
linker 
ABCD-serogroups 
105 – 108 cells·ml-1 
 
Wong et al. 
2002 
S. typhimurium 
Ab immobilized on the films of 
PEI-GA 
- 
1.5·109 CFU·ml-1 Babacan et al. 
2000 Ab immobilized on the films of 
protein Ǯ 
- 
1.5·109 CFU·ml-1 
Staphylococcus 
aureus  
Ab covalently immobilized by 
GA to self-assembled 
monolayer of thiolamin 
105 – 109 cells·ml-1 
- 
Boujday et al. 
2008 
Treponema  
pallidum 
Ab immobilized on the latex 
particle; latex agglutination 
- 
- 
Aizawa et al. 
2001 
Yersinia 
enterocolitica 
Direct detection, 
Ab immobilized via 
concanavalin A, sulfated 
polysaccharide 
(0.30 – 4.90) ·104 
cells·ml-1 
0.04·104 cells·ml- 
Kalmykova et 
al. 2007 
Vibrio cholera 
0139  
Adsorption of Ab 
- 
105 cells·ml-1 
Carter et al. 
1995 
Table 1. Piezoelectric immunosensors for the determination of bacteria  
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Most of the modern sensors are designed to determine the causative agents of a widespread 
group of intestinal diseases – bacteria E. coli (Plomer et al. 1992, Su and Li 2002, Adanyi et al. 
2006, Liu et al. 2007, Wang et al. 2008, Shen et al. 2011, Jiang et al. 2011, Li et al. 2011), Listeria 
monocytogenes (Minunni et al. 1996, Vaughan et al. 2002, Wang et al. 2008), Salmonella sp. (Su et 
al. 2001, Su et al. 2005, Yang et al. 2009, Park and Kim 1998, Wong et al. 2002, Fung and Wong 
2001, Ying-Sing et al 2000 ), Vibrio cholera (Carter et al. 1995), Yersinia enterocolitica 
(Kalmykova et al. 2007 and 2008), viruses (Konig and Gratzel 1992). (Adenovirus, and Rotavirus), 
as well as toxins (e.g. staphylococcus toxin) (Harteveld et al. 1997, Salmain et al. 2011).  
 
Analyte 
Method of immobilizing 
receptor molecules or assay 
design (detection format) 
Linear range. 
Detection limit 
References 
Adenovirus 
Direct assay, 
Ab immobilized via protein A, 
siloxane, polyethylenamine 
1·106 – 1·1010 
particulars·ml-1 
─ 
Konig et al. 
1992 
Hepatitis virus 
A, B 
Direct assay, 
Ab immobilized via protein A 
─ 
105 particulars·ml-1 
Zhou et al. 
2002 
Hepatitis virus 
С (HCV) 
RNA of HCV immobilized via 
avidin (streptavidin) to a 
monolayer of cystamine 
─ 
─ 
Skladal et al. 
2004 
Human 
cytomegalovirus
Competitive definition, 
monolayers of poly-L-lysine 
and tiosalicylic acid 
2.5 – 5 µg·ml-1 
1 µg·ml-1 
Susmel et al. 
2000 
Table 2. Piezoelectric immunosensors for the determination of viruses and bacteriophages  
Salmonellosis diagnostics is successfully carried out with the help of sensors with the 
biodetecting layer based on both common and thiolated antibodies (Park and Kim 1998, Kim 
et al. 2003), which are specific for the determined bacteria (S. typhimurium, S. paratyphi, S. 
enteritidis). Along with the traditional ways of antibody immobilization (physical 
adsorption, specific binding to protein A or covalent attachment using a bifunctional cross-
linker to the Langmuir-Blodgett films) in obtaining the biolayer self-organizing monolayers 
on polyethyleneimine (Wong et al. 2002, Babacan et al. 2000) and electropolymerization 
techniques are used.  
It should be noted that the method of electrode coating does not significantly affect the 
sensitivity of determining bacterial pathogens (105 - 109 cells·ml-1), but significantly increases 
the reproducibility and stability of analysis. For example, a sensor has been designed to 
determine the Staphylococcus aureus bacteria causing purulent-septic diseases (Le et al. 1995, 
Boujday et al. 2008). It is designed on the basis of the chromatographic phase (YWG-C18H37) 
with antibodies immobilized with glutaraldehyde and is meant for repeated use and long-
term storage. The sensor (Le et al. 1995) can be used up to 15 times and stored for months 
without a decrease in biomolecule activity. However, it is characterized by a few cases of 
cross-binding with bacteria of other genera: P. aeruginosa, S. epidermidis E. coli. The formation 
of the biolayer on the surface of an electropolimerized film increases the resistance of 
sensors that can be stored for more than 5 weeks. The ability to maintain constant values of 
the electrode’s potential and current provides for obtaining receptor coatings with identical 
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thickness, mass and distribution of functional groups, which is very important for 
commercial production of sensors.  
Despite the fact that most strains of E. coli are not harmful to humans, some serotypes (e.g. 
K12, O157: H7) cause serious food poisoning. Sensors are suggested for the "dip and dry" 
analysis with a receptor layer on the basis of antibodies to E. coli K12, immobilized on a 
 
Analyte 
Method of immobilizing 
receptor molecules or assay 
design (detection format) 
Linear range. 
Detection limit 
References 
Ab to bacteria F. 
tularensis 
Direct detection, 
Antigens are attached by means 
of GA to the cystamine-
monolayer on a gold electrode 
Titer 40 – 160 
- 
Pohanka et al. 
2007 
Ab to HIV 
Direct detection 
synthetic HIV-peptide or 
recombinant proteins are 
immobilized 
Tests yes/no 
Kosslinger et 
al. 1995 and 
1998 
Ab to parasites 
Shistosoma 
japonicum 
Antigens (SjAg32, mass 32kD) 
covalently immobilized on 3-
mercaptopropionic SAM-to you 
(MPA) using EDC/NHS 
3.6 – 42.0 µg·ml-1 
- 
Wu et al. 2003 
Ab to bacteria 
Y.enterocolitica 
Direct assay, 
LPS immobilized 
on a lipid substrate 
3 – 110 µg·ml-1 
1.3 µg·ml-1 
Kalmyken et 
al. 2007 
Immuno- 
globulin Е 
Direct assay, 
Physical sorption of protein 
antigen 
0 – 300 МЕ·ml-1 
0.1 – 25 µg ·ml-1 
0.15 – 17.5 µg·ml-1 
– 
Su et al. 2000 
Immuno- 
globulin Е 
Direct assay, 
Affine immobilization to 
aptomer on the basis of ssDNA
– 
0.05 nmol·ml-1 
Liss et al. 2000 
Human IgG 
Direct assay, 
Chemo sorption of protein 
complex IgG-Ǯb on polystyrene 
substrate 
– 
5 µg·ml-1 
Liu et al. 2003 
Surface antigen 
of Hepatitis B 
Direct assay, 
Ab linked by method of cross-
linkikg to cystimine monolayer
– 
4.7 nmol·l-1 
Chen et al. 
2002 
Cholera toxin 
Sandwich method, 
amplified by ganglioside-
modified liposomes 
– 
0.0001 nmol·l-1 
Alfonta and 
Wilner 2001 
Staphylococcus 
enterotoxin 
(SEB) 
Competitive assay, 
Ab immobilized on god 
electrode 
– 
0.1 µg·ml-1 
Harteveld et al. 
1997 
Table 3. Piezoelectric immunosensors for determination of protein molecules  
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substrate of protein A (Plomer et al. 1992) and monolayers on alkanthiols (Su and Li 2002). 
The detection limit of bacteria E. coli 0157: H7 is 103 CFU·ml-1. In order to increase the 
sensitivity of the determination of E. coli O157: H7 streptavidin-conjugated nanoparticles 
gold (145 nm), magnetic, silica and polymer nanoparticles of 30 - 970 nm, immunomagnetic 
nanoparticles (BIMPs) and affinity-purified antibodies against E.coli treated with biotin (Liu 
et al. 2007, Shen et al. 2011, Jiang et al. 2011) are used. After binding cells with immobilized 
antibodies nanoparticles of bio-conjugates with streptavidin are injected into the system (Liu 
et al. 2007), thus amplifying the sensor’s signal, with the detection limit of bacteria E. coli 
O157: H7 decreasing to 102 CFU·ml-1. 
Besides the research aimed at determining certain types of bacteria, in microbiological 
control it is possible to simultaneously determine several of the most dangerous micro-
organisms belonging to the same family (Kim and Bhunia 2008). It is perspective to apply 
antibodies against enterobacterial common antigen (ECA) which represents a phospholipid 
in the outer membrane and characterized by specificity to the whole Enterobacteriaceae family 
comprising the Salmonella and E. coli genera. Using monoclonal antibodies to ECA, Plomer 
et al proposed immunosensors for determining any microorganism of the Enterobacteriaceae 
family in the range of 104 - 106 cells·ml-1.  
This displacement analysis is recommended for determining the Pseudomonas aeruginosa 
bacteria which cause postoperative or post-burn complications. In order to determine the 
bacteria directly in the flow of the solution thiolated antibodies (Kim et al. 2004) were used, 
which increases its service life by more than 10%.  
A method has been suggested for flow-injection determination of pathogenic "fridge 
bacteria" – the Yersinia enterocolitica bacteria, O:3 serotype, in aqueous media. The necessity 
to determine Yersinia is caused by the fact that they are agents of an infectious intestinal 
disease – yersiniosis which considerably influences human and animal pathology. In order 
to determine the Y. enterocolitica bacteria the biolayer of the sensor is formed on immobilized 
specific antibodies. The comparative evaluation of methods for obtaining the bio-detecting 
layer of the sensor (absorption of antibodies on metal surfaces, covalent binding with 
sulfated polysaccharides substrates, concanavalin A, aminosiloxane using glutaraldehyde) 
has demonstrated the advantage of polysaccharide substrates, which increase the 
reproducibility of the analytical signal and reduce the detection limit to 0.02·104 cells·ml-1 
(Kalmyken et al. 2007). The widest linear range of determined microorganisms was found 
for the siloxane biolayer substrate: 0.30 - 4.90·104 cells·ml-1. The methods of flow-injection 
determination of the Y. enterocolitica bacteria using a piezo-quartz immunosensor with the 
biolayer based on monoclonal homologous antibodies can reliably detect the presence of 
microorganisms in aqueous media. The proposed immunosensors can detect bacteria in 
water solutions with a minimum concentration of 0.10·104 cells·ml-1. 
Despite very rare occurrences of cholera in this day and age, it is an infection which can 
cause rapid dehydration and death. In order to determine the Vibrio cholerae 0139 a highly 
specific sensor was developed (Carter et al. 1995) showing no cross-interactions with other 
bacteria, such as Ogawa, E.coli, L. monocytogenes and S. marcescens.  
Piezoelectric biosensors can be applicable not only in determining individual analytes, but 
also for the study of biochemical processes (agglutination, hybridization) in real time, as 
well as of the kinetics of reversible reactions. Such sensors can subsequently be used to 
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select antibodies as bioreceptor molecules to create immunosensors. For example, 
researchers deal with the application of monoclonal antibodies against pathogenic 
Francisella tularensis bacteria causing a zoonotic disease – tularaemia, as well as bacterial 
endotoxins to determine specific antibodies (Pohanka et al. 2007). 
Viruses. Among all infectious diseases the most complicated problems are associated with 
viral infections. This is mainly due to the prevalence of viruses, their participation in the 
processes of immunogenesis, difficulty in diagnoses, so it is equally important to create 
sensors for the determination of pathogenic viruses (hepatitis, herpes, human 
immunodeficiency - HIV, etc.).  
One of the first researchers who reported on the possibility of detecting not only bacterial, 
but viral pathogens of diarrhea (Rotavirus and Adenovirus) in liquid were Konig and Gratsel. 
The sensors designed by these authors allow the determination of both the microbial 
pathogens in the range of 1·106 - 1·108 and 1·106 - 1·1010 virus·ml-1, respectively, as a result of 
direct increment of the mass of the receptor layer. The direct detection is used to determine 
the herpes viruses 1 and 2, Varicella-zoster, Epstein-Barr virus at 104 virus·ml (Susmel et al. 
2001). In the case of hepatitis A and B, the detection limit is 105 viral particles·ml-1 (Konig 
and Gratsel 1995, Zhou et al. 2002). When testing serum samples for viral presence with the 
application of specific antibodies absorbed on the surface of the crystal, screening was 
carried out to determine the content of viral particles; the results were correlated with those 
of the enzyme-linked immunosorbent assay. 
In order to determine human cytomegalovirus the competitive immunoassay (Susmel et al. 
2001) is recommended, as direct cooptation of the virus from the solution gives poor results 
(Konig and Gratsel 1995), while the competitive analysis, performed with a monolayer on 
poly-L-lysine (covalently bonded to the monolayer of tiosalicylic acid) allows the detection 
of the antigen in the range of 2.5 to 5 mg·ml-1, the detection limit being 1 mg·ml-1.  
Antibodies and bacteriotoxins. Antibodies of various specificity, and some protein toxins 
can act as biomarkers of infectious and somatic diseases. The first researches on determining 
antibodies to human immunodeficiency virus (Kosslinger et al. 1995, Kosslinger et al. 1998) 
were reported in 1992. Their authors used synthetic peptides of human immunodeficiency 
virus (HIV) as receptor molecules immobilized on the surface of the electrode of a high-
frequency resonator (20 MHz). The influence of the dilution of a serum sample on the 
reliability of the determination is shown.  
The sandwich-analysis with the recombinant protein as receptor molecules and the 
amplification of the signal by secondary antibodies labelled with an enzyme was used to 
assess patients' contamination by the Helicobacter pylori bacteria, detectable by the presence 
of specific antibodies in serum (Su and Li 2001). The sensor can be used both in static and 
flow modes.  
Determining specific antibodies in infectious yersiniosis (caused by the Yersinia enterocolitica 
bacteria) allows differentiating an acute intestinal infection from surgical pathology (e.g. 
acute appendicitis), which provides the correct choice of therapeutic measures and the 
identification of chronic forms of the disease. A sensor is proposed with the receptor layer 
on the basis of lipopolysaccharides (LPS) – components of the outer membrane of the cell 
wall of Gram-negative bacteria, consisting of covalently linked (Kalmykova et al. 2006 and 
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2007) carbohydrate and lipid parts. In determining specific antibodies it is necessary to 
provide spatial availability for carbohydrate, and not lipid, LPS (O-specific polysaccharides) 
macromolecules. Activation of silver electrodes is carried out with lipids of oil, Fig. 11.  
The application of a hydrophobic electrode modifier for the immobilization of 
lipopolysaccharides leads to the interaction of the lipid part of macromolecules with a lipid 
coating and the orientation of O-specific polysaccharide chains (O-antigenic determinants) 
in the direction of the hydrophilic eluent (Fig. 11). At the same time the biolayer is 
characterized by maximum binding activity with corresponding antibodies.  
 
Fig. 11. The interaction of LPS with antibodies immobilized on a hydrophobic substrate (oil) 
(Kalmykova et al. 2007) 
The significance of this research lies in both determining antibodies and establishing a 
correlation between different ways to express the activity of sera (activity titre and the 
concentration of specific antibodies). The sensor allows the determination of antibodies in 
serum with a higher sensitivity compared with the reaction of passive hemagglutination. This 
is useful for identifying yersiniosis at an earlier stage and monitoring treatment efficiency.  
Another area in the application of sensors is the detection of parasites Shistosoma japonicum 
(Wu et al. 2003, Wu et al. 2006, Cheng et al. 2008) when specific antibodies are determined in 
blood as a result of polymer agglutination. 
Of special interest are sensors for the determination of certain classes of antibodies – IgA, 
IgG, IgM, which can serve as indirect indicators of candidiasis and facilitate the diagnostics 
of fungal infections.  
Determination of antibodies to DNA. One of the clinical forms of yersiniosis is the arthritic 
one, when patients with rheumatoid arthritis have antibodies to the Y. enterocolitica bacteria, 
serotype O:5. However, more often the arthritic pathology is an indicator of developing 
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autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, chronic 
glomerulonephritis, etc. when antibodies to DNA are formed in the body itself. 
Immunosensors have been designed based on denatured DNA molecules for determining 
antibodies to DNA in blood serum (Fakhrullin et al. 2007, Kalmykova et al. 2003) in the 
range of 0.1 - 25 μg·ml-1 (0.03 – 8 IU), the detection limit being 0.01 μg·ml-1 (0.003 IU). Other 
substances of protein nature in blood plasma does not interfere with the quantitative 
determination of antibodies to DNA. 
4. Conclusion  
Possible practical applications of piezoelectric immunosensors are not limited to the 
examples discussed above. The analysis of papers published over the past 15 years shows 
that the new research direction, connected with the development and application of 
piezoelectric immunosensors, causes a growing concern around the world. Sensors are used 
in clinical diagnostics to identify high and low molecular compounds, to monitor the 
effectiveness of drugs action and their metabolism, to identify the causes of the intoxication 
of the body, to detect drug and doping agents in biological fluids.  
The relatively low cost combined with high sensitivity and selectivity, plus the possibility to 
analyze just one drop of blood, saliva, or urine with little or no additional sample 
preparation, the resumption of the activity of the bioreceptor layer and multiple use make 
piezoelectric immunosensors a real alternative to the existing methods used in medicine.  
Besides, the combination of piezoelectric micro- and nano-weighing with other methods 
(e.g. optical or electrochemical methods, the surface plasmon resonance method, the method 
of atomic force microscopy) will contribute to a better understanding of biochemical 
processes at the cellular level, leading to various diseases. 
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